Clinical Trials Logo

Diabetic Polyneuropathy clinical trials

View clinical trials related to Diabetic Polyneuropathy.

Filter by:

NCT ID: NCT05457192 Recruiting - Clinical trials for Diabetic Polyneuropathy

Correlation of HbA1c With Electrophysiological Studies and Gait Performance in Diabetic Polyneuropathy Patients

Start date: July 2022
Phase:
Study type: Observational

This study will be conducted to investigate the relationship between glycosylated hemoglobin (HbA1c) and nerve conduction studies (NCS) with gait performance in patients with DPN. 65 patients with type II DM with moderate polyneuropathy will participate in this study. Glycosylated Hemoglobin (HbA1c) test will be done for each patient by using the Colorimeter device. Nerve conduction studies (NCS) will be performed for each patient by using the electromyography device to confirm the diagnosis of DPN. The neurophysiological functions of peripheral nerves including (The Common peroneal, Tibial, Sural, and Ulnar motor & sensory branches) will be measured. Spatiotemporal gait parameters (stride length, cadence& velocity) for all the patients will be assessed by two-dimension video-based motion analysis (2D).

NCT ID: NCT05115747 Completed - Clinical trials for Diabetic Polyneuropathy

Effect of Alter-G Training on Glycemic Control and Quality of Life in Diabetic Neuropathy

Start date: January 15, 2021
Phase: N/A
Study type: Interventional

Aging is a natural process that is frequently accompanied by chronic physical or mental health problems. Aging as well as a sedentary lifestyle behavior may produce identical pathological and morphological changes. Saudi population, especially elderly people assume sedentary lifestyle, with little physical activity is a strong predisposition for developing a disability that adversely affects many aspects of physical and mental functions; mainly mobility and the ability to perform the basic daily living activities (ADL); resulting finally in increased risk of independence, loss of functionality, and falls. Type 2 diabetes mellitus (T2DM) is a widespread chronic metabolic disorder, accounts for 90-95% of all patients with diabetes. It is one of the most life-threatening public health challenges in the world, characterized by long term complications that almost involves all systems of the body. Polyneuropathy is the most common symptomatic complication in patients with type 2 diabetes mellitus, found in 50 to 60 % of patients over the age of sixty, with the impaired glycemic control and deteriorated quality of life are among the most debilitating problems in patients with diabetic polyneuropathy.

NCT ID: NCT05088993 Completed - Clinical trials for Diabetic Polyneuropathy

Effects of Antigravity Treadmill Training on Gait and Balance in Patients With Diabetic Polyneuropathy

Start date: February 15, 2021
Phase: N/A
Study type: Interventional

Aging can be defined as sequential deterioration that occurs in elderly people including weakness, loss of mobility, decline of physical capabilities, increase susceptibility to disease and many other age-related physiological changes .The beginning of old age in most developed countries is about 60 or 65 years old. Diabetes mellitus (DM) and most commonly type 2 DM is one of the most common chronic non-communicable diseases affecting old people in Saudi Arabia which might be resulted from decline in physical activities. Polyneuropathy (PN) and its serious consequences represent the most common complication in diabetic mellitus which could contribute to an increased gait abnormality and risk of falling.

NCT ID: NCT04620265 Completed - Clinical trials for Diabetic Polyneuropathy

Differential Air Pressure Technology for Treatment of Diabetic Elderly Patients

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Aging can be defined as sequential deterioration that occurs in elderly people including weakness, loss of mobility, decline of physical capabilities, increase susceptibility to disease and many other age-related physiological changes .The beginning of old age in most developed countries is about 60 or 65 years old. Diabetes mellitus (DM) and most commonly type 2 DM is one of the most common chronic non-communicable diseases affecting old people in Saudi Arabia which might be resulted from decline in physical activities. Polyneuropathy (PN) and its serious consequences represent the most common complication in diabetic mellitus which could contribute to an increased gait abnormality and risk of falling.

NCT ID: NCT04593992 Completed - Clinical trials for Diabetic Polyneuropathy

HTEMS Treatment of Diabetic Polyneuropathy

HTEMS-RCT
Start date: October 20, 2020
Phase: N/A
Study type: Interventional

So far, there are no sufficient pharmacologic therapies for the treatment of diabetic neuropathy. Therefore, we evaluated application of high-tone external muscle stimulation (HTEMS) compared to placebo treatment in patients with diabetic neuropathy.

NCT ID: NCT04516200 Not yet recruiting - Clinical trials for Diabetic Polyneuropathy

Effect of Transcranial Direct Current Stimulation on Sensory Integration

Start date: August 2020
Phase: N/A
Study type: Interventional

To determine the effect of Transcranial direct current stimulation on sensory integration and risk of falling in diabetic polyneuropathy.

NCT ID: NCT04325347 Completed - Clinical trials for Diabetic Polyneuropathy

VR in Diabetic Polyneuropathy

Start date: January 27, 2021
Phase: N/A
Study type: Interventional

This study is an experimental single centre study investigating the effect of VR on overall sleep quality and number of awakenings in patients with diabetic polyneuropathy.

NCT ID: NCT04322240 Completed - Clinical trials for Diabetes Mellitus, Type 2

Alpha Lipoic Acid and Diabetes Mellitus: Potential Effects on Peripheral Neuropathy

Start date: April 2, 2020
Phase: N/A
Study type: Interventional

Patients with type 2 DM who are following will be enrolled into the study. Two visits were scheduled for data collection, physical examination and laboratory testing of the patients: the first prior to initiation of alpha lipoic acid (ALA) administration (baseline visit) and the second at the end of the third month following initiation of ALA (2nd visit).

NCT ID: NCT04119167 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in Asians

Start date: August 1, 2019
Phase:
Study type: Observational

Significant differences in the expression of individual Growth Differentiation Factor 15 (GDF-15) proteins among Taiwanese harboring different mitochondrial genotypes are noted, and their blood serum levels also exhibited associations with diabetes. GDF-15 was originally discovered as an autocrine regulator of macrophage activation and shown to play important roles in fibrosis, malignancy, cardiovascular disease, glycemic control, and obesity. However, the relationship between GDF-15 and pre-diabetes and diabetes in Asian populations has yet to be fully investigated. Besides, any indirect associations between GDF-15 levels and diabetic complications remain unclear. The investigators aim to further investigate the role of GDF-15 levels in the initial diagnosis of diabetes, the monitoring of medication effectiveness and disease progression, and related complications such as diabetic nephropathy and neuropathy. The DNA isolated from the blood samples will be evaluated to determine individual mitochondria haplogroups, including variants located within the coding and control regions of the mitochondrial genome.

NCT ID: NCT03934970 Completed - Clinical trials for Magnetic Resonance Imaging

Diffusion Tensor Imaging of Median Nerve in Diabetic Peripheral Neuropathy

Start date: April 30, 2015
Phase:
Study type: Observational

This study is a diagnostic accuracy study that aims to evaluate the role of DTI in evaluation of DPN in comparison to clinical scores and nerve conduction studies (NCS). The study included 30 patients with diabetes mellitus complaining of neuropathy symptoms and 15 healthy volunteers. All subjects underwent evaluation using 1.5T DTI of median nerves and NCS. Patients underwent clinical evaluation using Neuropathy Deficit Score (NDS), Neuropathy Impairment Score in the Lower Limbs (NIS-LL) and Diabetic Neuropathy Examination (DNE) score. The values of these tests were compared and correlated and diagnostic accuracy tests were performed together with identification of cut-off score for abnormal diffusion tensor imaging parameters in diabetic neuropathy